Advertisement

ADVERTISEMENT

Jessica Garlewicz, Associate Digital Editor

Mark Lebwohl, MD,
Conference Coverage
From TNF-Inhibitors to JAKs: Which Therapy for Which Patient?
10/23/2022
During his session presented at the 2022 Fall Clinical Dermatology Conference, Mark Lebwohl, MD, went over the many treatment options for patients with psoriasis.
During his session presented at the 2022 Fall Clinical Dermatology Conference, Mark Lebwohl, MD, went over the many treatment options for patients with psoriasis.
During his session presented at...
10/23/2022
The Dermatologist
psoriasis severe
Conference Coverage
IL-17 Blockers: Updates on the Safety and Efficacy for Psoriasis
10/22/2022
During her session, “IL-17 Blockers: Safety and Efficacy,” Boni E. Elewski, MD, went over the efficacy and safety of some of the IL-17 blockers used to treat psoriasis, and more.
During her session, “IL-17 Blockers: Safety and Efficacy,” Boni E. Elewski, MD, went over the efficacy and safety of some of the IL-17 blockers used to treat psoriasis, and more.
During her session, “IL-17...
10/22/2022
The Dermatologist
melanoma
Conference Coverage
Pre-Existing Therapies and More Down the Pipeline: Updates in Melanoma
10/21/2022
During her session at the 2022 Fall Clinical Dermatology Conference, Laura K. Ferris, MD, PhD, went over the importance of immunotherapy, collaborative care, and more when treating patients with melanoma.
During her session at the 2022 Fall Clinical Dermatology Conference, Laura K. Ferris, MD, PhD, went over the importance of immunotherapy, collaborative care, and more when treating patients with melanoma.
During her session at the 2022...
10/21/2022
The Dermatologist
Elizabeth Swanson, MD
Conference Coverage
Pediatric Dermatology: Psoriasis, Atopic Dermatitis, and More
10/21/2022
In her session, “What's New and Hot in Pediatric Dermatology,” Elizabeth Swanson, MD, shared her experiences and tips on treating pediatric patients within her clinic.
In her session, “What's New and Hot in Pediatric Dermatology,” Elizabeth Swanson, MD, shared her experiences and tips on treating pediatric patients within her clinic.
In her session, “What's New and...
10/21/2022
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
From Psoriasis to Atopic Dermatitis: Insights Into Topical Therapy
10/21/2022
During her session, “What's New and Hot in Topical Therapy,” Linda F. Stein Gold, MD, imparted some of the best practices physicians can implement when using topical therapy in their clinic.
During her session, “What's New and Hot in Topical Therapy,” Linda F. Stein Gold, MD, imparted some of the best practices physicians can implement when using topical therapy in their clinic.
During her session, “What's New...
10/21/2022
The Dermatologist
April W. Armstrong, MD, MPH
Conference Coverage
IL-17 Inhibitors: Psoriasis and Beyond
10/21/2022
In their session presented at the 2022 Fall Clinical Dermatology Conference, April W. Armstrong, MD, MPH, and Bruce E. Strober, MD, PhD, shared insights into the roles of IL-17 inhibitors.
In their session presented at the 2022 Fall Clinical Dermatology Conference, April W. Armstrong, MD, MPH, and Bruce E. Strober, MD, PhD, shared insights into the roles of IL-17 inhibitors.
In their session presented at...
10/21/2022
The Dermatologist
swanson
Conference Coverage
Down the Pipeline: JAK Inhibitors in Atopic Dermatitis
10/20/2022
During their session at 2022 Fall Clinical, James Q. Del Rosso, DO, and Elizabeth Swanson, MD, went over the current JAK inhibitors available to patients with AD.
During their session at 2022 Fall Clinical, James Q. Del Rosso, DO, and Elizabeth Swanson, MD, went over the current JAK inhibitors available to patients with AD.
During their session at 2022...
10/20/2022
The Dermatologist
Conference Highlights
Dermatology Week Fall: New Insights and Updates
10/18/2022
This year’s fall Dermatology Week delivered education for today’s providers in a fully virtual event.
This year’s fall Dermatology Week delivered education for today’s providers in a fully virtual event.
This year’s fall Dermatology...
10/18/2022
The Dermatologist
Clinical Insights
Update on Dupilumab for Children With Atopic Dermatitis
10/18/2022
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved...
10/18/2022
The Dermatologist
Jashin Wu, MD, FAAD
Q&As
Psoriasis and Metabolic Syndrome
10/14/2022
A recent abstract summarized the current knowledge surrounding inflammatory mechanisms shared between psoriasis and metabolic syndrome.
A recent abstract summarized the current knowledge surrounding inflammatory mechanisms shared between psoriasis and metabolic syndrome.
A recent abstract summarized the...
10/14/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use